Therefore, screening for LAMA2 point mutations, followed by analysis of LAMA2 CNVs, especially exon 4 deletion, may be appropriate as an initial strategy for patients with features consistent with congenital muscular dystrophy, such as muscular dystrophy combined with white matter changes in brain MRI. Here, LAMA2 is linked to congenital muscular dystrophy.